Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm
A legfontosabb adatok
- Ki végzi
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Hol
- Beijing (Kína)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 73 fő, tervezett
- Kezdés
- 2023. jún. 1.
- Várható befejezés
- 2028. máj. 30.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- multibranched stent graft system
- A regiszteradat frissítve
- 2024. július 12.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a thoracoabdominal aortic aneurysm (a bulge in the main artery across the chest and belly). They would be treated through the blood vessels with a multibranched stent graft system.
- Életkor
- 18 to 80 years
- Nem
- All sexes
- A betegség stádiuma
- Thoracoabdominal aortic aneurysm with at least one of these: largest diameter >50 mm; growth >5 mm in the last 6 months or >10 mm within 1 year; or symptoms such as clear belly or back pain. The artery shape and size must fit the device, and the vessels in the groin and arm must allow access.
- Korábbi kezelés
- People who had major surgery or a major procedure through the blood vessels within 30 days before surgery cannot join.
A részvétel fő kizáró okai
- Burst aneurysm with unstable blood pressure and circulation, an aortic dissection with an aneurysm, or an infected aneurysm
- Blocked gut or kidney arteries, or severe narrowing, calcium or clot where the graft would sit
- Heart attack or unstable angina within 6 months, or mini-stroke (TIA) or stroke within 3 months
- Liver tests (ALT or AST) ≥ 5 times the upper limit of normal, or serum creatinine ≥ 150 μmol/L (1,7 mg/dL)
- Connective tissue disease or Takayasu arteritis, pregnancy, planning pregnancy or breastfeeding
A regiszter feltételei, szó szerint
Mind a 26 feltétel megnézéseKevesebb
Ki vehet részt
- Age ≥18 and ≤80 years
- Patients diagnosed with thoracoabdominal aortic aneurysm (based on the modified Crawford classification and the 2019 European guidelines for the treatment of aortic aneurysms), and should meet at least one of the following conditions:; Maximum diameter of TAAA >50 mm,; Rapid growth of sac >5 mm in diameter in the most recent 6 months, or rapid growth >10 mm in diameter within 1 year; Symptoms related to thoracoabdominal aortic aneurysm, such as clear abdominal pain and back pain
- Anatomical criteria, including:; Proximal landing zone 17-36 mm in diameter and ≥25 mm in length; If distal landing zone in abdominal aorta:Distal landing zone 12-36 mm in diameter and ≥20 mm in length If distal landing zone in iliac artery:Distal landing zone 7-25 mm in diameter and ≥15 mm in length; Visceral vessel landing zone 6-13 mm in diameter and ≥15 mm in length; Renal artery landing zone 4.5-9 mm in diameter and ≥15 mm in length
- Patients with Feasible iliofemoral artery and upper patent upper extremity access
- Patients who can understand the purpose of the trial, voluntarily participate and sign the informed consent form, and are willing to complete the follow-up according to the requirements of the protocol
Ki nem vehet részt
- Undergone major surgical or interventionic surgery within 30 days before surgery
- Ruptured aortic aneurysm in unstable haemodynamic condition
- Infected or mycotic aortic aneurysm
- Patients whose systemic or local infection may increase the risk of intravascular graft infection
- Diagnosis of acute coronary syndrome within 6 months; Acute coronary syndrome refers to an acute cardiac ischemia syndrome caused by the rupture or erosion of unstable atherosclerotic plaques in the coronary arteries, which is followed by the formation of fresh thrombus. It includes ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, and unstable angina pectoris
- Patients with any transient ischemic attack (TIA) or ischemic stroke within 3 months
- Severe pulmonary insufficiency who cannot tolerate general anaesthesia
- An allergic history for contrast agents, anticoagulants, antiplatelet drugs, stent graft or materials of delivery system( (referring to nickel-titanium, polyester, PTFE, nylon-based polymer materials)
- Patients with connective tissue diseases, such as systemic lupus erythematosus, Marfan syndrome, Ehlers-Danlos syndrome, or Behcet's disease
- Patients with serious vital organ dysfunction or other serious disease
- Preoperative liver renal function abnormalities (ALT or AST ≥ 5 times the upper limit of normal value), or serum creatinine ≥ 150 μmol/L
- Aneurysmal aortic dissection
- Patients with occlusion of the superior mesenteric artery, celiac trunk, or renal artery
- Requiring simultaneous coverage or embolisation for bilateral internal iliac arteries
- Severe stenosis, calcification, or mural thrombus at stent-graft landing zone
- Severe coagulation dysfunction
- Patients with takayasu arteritis
- Planning pregnancy, pregnancy, or breastfeeding
- The patient participated in other clinical trials or not completed or withdrawn from other clinical trials within the last 3 months at the time of screening period
- Life expectancy less than 1 year
- Patients who are not appropriate for endovascular repair based on the investigators' clinical judgement
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 80 év között vagy?
Helyszínek itt: Kína
- Chinese PLA General HospitalBeijing, KínaContact: Wei Guo, ProfessorRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The objective of this study is to evaluate the feasibility of multibranched stent graft system for Endovascular Treatment of Thoracoabdominal Aortic Aneurysm(TAAA)
A vizsgálat csoportja
- multibranched stent graft systemA vizsgált kezelés
Endovascular treatment of patients withThoracoabdominal Aortic Aneurysm using multibranched stent graft system
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- GUo's Renovisceral Artery Reconstruction-2: a Prospective,Single Center,Single-arm Clinical Trial to Evaluate the Safety and Efficacy of a multibRANched sTEnt Graft systEm for Thoracoabdominal Aortic Aneurysm
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT06478576: ki vehet részt
- A regiszteradat frissítve
- 2024. július 12.